Resona Asset Management’s Legend Biotech LEGN Stock Holding History

Resona Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$581K	Sell	20,068 -318	-2%	-$8.58K	﹤0.01%	675
2026 Q1	$366K	Buy	20,386 +607	+3%	+$11.6K	﹤0.01%	710
2025 Q4	$430K	Hold	19,779	–	–	﹤0.01%	705
2025 Q3	$646K	Sell	19,779 -2,122	-10%	-$78.3K	﹤0.01%	671
2025 Q2	$775K	Buy	21,901 +4,451	+26%	+$144K	﹤0.01%	656
2025 Q1	$595K	Hold	17,450	–	–	﹤0.01%	674
2024 Q4	$568K	Sell	17,450 -4,228	-20%	-$175K	﹤0.01%	694
2024 Q3	$1.06M	Buy	21,678 +2,636	+14%	+$140K	0.01%	653
2024 Q2	$844K	Hold	19,042	–	–	0.01%	666
2024 Q1	$1.07M	Buy	+19,042	New	+$1.15M	0.01%	658

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Resona Asset Management's LEGN Position: Q2 2026 in Review

Resona Asset Management reduced its Legend Biotech (LEGN) stake by 1.6% in Q2 2026, selling an estimated $8.58K and leaving 20,068 shares worth $581K. The position accounts for ﹤0.01% of the portfolio, ranked #675.

Resona Asset Management first reported a position in LEGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.07M in Q1 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Resona Asset Management held 20,068 shares of Legend Biotech worth $581K as of Q2 2026.
Resona Asset Management sold 318 Legend Biotech shares in Q2 2026, an estimated $8.58K.
Legend Biotech made up ﹤0.01% of Resona Asset Management's portfolio in Q2 2026, its #675 holding.
Resona Asset Management first reported a position in Legend Biotech in Q1 2024 and has held it in 10 quarters since.
Resona Asset Management's Legend Biotech position peaked at $1.07M in Q1 2024.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.